SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech fireworks
An SI Board Since October 2001
Posts SubjectMarks Bans
7424 223 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7224MYOK up 30%+ premarket on good PII data: finance.yahoo.comIRWIN JAMES FRANKEL18/7/2017
7223CARA about 23% on manifestations of that Breakthrough Therapy designation: in antuck-8/4/2017
7222ONCE on generally upbeat news assd. with earnings release, and mention of a potescaram(o)uche-8/2/2017
7221FDA panel says data supports safety of Dynavax hepatitis B vaccine Dynavax TechnJulius Wong-7/28/2017
7220SRPT 20-odd% on earnings.nigel bates-7/20/2017
7219BGNE +26%tnsaf-7/7/2017
7218CARA Therapeutics given breakthrough status for I.V. CR845, floating around 15%.D.Lu-6/23/2017
7217CLVS +46% on trial resultstnsaf-6/19/2017
7216RIGL +13.2% FDA has accepted the New Drug Applicationmopgcw-6/19/2017
7215Omeros (OMER) his the 15% mark with this news: FDA Grants Breakthrough Therapy D.Lu-6/13/2017
7214LOXO on weekend ASCO news Loxo Oncology Announces Clinical Proof of Concept Publtnsaf-6/6/2017
7213IMMY up over 15% - second day in a row for that intraday. No idea why.IRWIN JAMES FRANKEL-6/2/2017
7212Unexpected cardiovascular risk with Amgen and UCB's romosozumab and longer tJulius Wong-5/22/2017
7211Sangamo (SGMO) up over 50% reflecting collaboration with Pfizer to develop and mD.Lu-5/11/2017
7210Pieris (PIRS), gave up some of the gains from the announcement of the AZ deal ovtuck-5/10/2017
7209rxdx, up 16% on sort of an easy call. Lots of mistakes in off-hour pricing thesscaram(o)uche-5/4/2017
7208Pieris (PIRS) up about 35% on AstraZeneca deal for respiratory diseases. BJ andtuck-5/3/2017
7207Akebia Therapeutics (AKBA) up 36% on expansion of partnership with Otsuka PharmaD.Lu-4/26/2017
7206OCRX +40%/AH on rat data: investorshub.advfn.comDewDiligence_on_SI-4/12/2017
7205CNAT, NBIX (AH)tnsaf-4/12/2017
7204FGEN up 15% on pricing the offering. + LT tell per Peter.IRWIN JAMES FRANKEL-4/6/2017
7203PRTK +35% AH on study resultstnsaf-4/3/2017
7202Sangamo (SGMO) up c.13% after being over 15% earlier on ALZ study done at Mass GD.Lu-3/29/2017
7201Catalyst (CBIO) up almost 200% on an IND approval in South Korea. Good luck gettuck-3/28/2017
7200IMMY up over 20% Probably part oversold bounce and realizing stock sales over fIRWIN JAMES FRANKEL-3/28/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News